🔗 Share this article TikTok Content Creators Driving Unofficial Trade for Unlicensed Slimming Medication An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations. Experimental Treatment Gaining Popularity Via Social Media The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts directly for source information, while also obtaining discount codes. Active Commerce on Messaging Platforms Separately, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for transactions. Learning About Retatrutide Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic. Medical Experts Express Concerns However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source. Some experts said the demand for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro. Legal Position and Implementation Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations. Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment. Service Response and Content Elimination According to TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The company stated it was committed to maintaining the service safe and investing in strengthening enforcement strategies. Online Marketplace Operations Research also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, populated with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence. After minutes of entering one group, a vendor posted contact information, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or past usage. Item Details and Costs Within these groups, messages display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”. Service Moderation and Security Measures A spokesperson for the messaging service stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”. Healthcare Expert Warnings “Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U. A medical professional of an online medical service connected the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said. Her staff has previously seen individuals harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.” Manufacturer Position A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may subject users to potentially serious medical dangers”.